Overview
Jan Warnking practices practicing medicine in Grenoble, France.
Warnking is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Cerebral Hypoxia, Cerebral Amyloid Angiopathy, and Primary Amyloidosis.
They are actively involved in clinical research, co-authoring 26 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jan M. Warnking
Is Jan M. Warnking a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Jan M. Warnking is classified as an Advanced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jan M. Warnking participate in research or clinical trials?
Yes. Jan M. Warnking has published 26 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Jan M. Warnking's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cerebral HypoxiaWarnking isAdvanced. Learn about Cerebral Hypoxia.
- Experienced
- Cerebral Amyloid AngiopathyWarnking isExperienced. Learn about Cerebral Amyloid Angiopathy.
- Primary AmyloidosisWarnking isExperienced. Learn about Primary Amyloidosis.